Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

and in laboratory tests they showed high neutralization of all the variants of SARS-CoV-2 known to cause illness in humans.

The following is a summary of “Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity,” published in the March 2025 issue of ...

Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...

Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

Starting from April 8, people aged 65 and older, indigenous people aged 55 to 64, children younger than six months old and ...